Luis David Jiménez‐Franco

619 total citations
13 papers, 420 citations indexed

About

Luis David Jiménez‐Franco is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luis David Jiménez‐Franco has authored 13 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Oncology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luis David Jiménez‐Franco's work include Radiopharmaceutical Chemistry and Applications (8 papers), Medical Imaging Techniques and Applications (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Luis David Jiménez‐Franco is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (8 papers), Medical Imaging Techniques and Applications (5 papers) and Neuroendocrine Tumor Research Advances (3 papers). Luis David Jiménez‐Franco collaborates with scholars based in Germany, Netherlands and Austria. Luis David Jiménez‐Franco's co-authors include Andreas Kluge, Gerhard Glatting, Fabian Staudinger, Manuel Röhrich, Mustafa Syed, Clemens Kratochwil, Paul Flechsig, Jürgen Debus, Sebastian Regnery and Uwe Haberkorn and has published in prestigious journals such as Medical Physics, Journal of Nuclear Medicine and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Luis David Jiménez‐Franco

11 papers receiving 419 citations

Peers

Countries citing papers authored by Luis David Jiménez‐Franco

Since Specialization

Citations

This map shows the geographic impact of Luis David Jiménez‐Franco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis David Jiménez‐Franco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis David Jiménez‐Franco more than expected).

Fields of papers citing papers by Luis David Jiménez‐Franco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis David Jiménez‐Franco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis David Jiménez‐Franco. The network helps show where Luis David Jiménez‐Franco may publish in the future.

Co-authorship network of co-authors of Luis David Jiménez‐Franco

This figure shows the co-authorship network connecting the top 25 collaborators of Luis David Jiménez‐Franco. A scholar is included among the top collaborators of Luis David Jiménez‐Franco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis David Jiménez‐Franco. Luis David Jiménez‐Franco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Whole-Body Physiologically Based Pharmacokinetic Modeling Framework for Tissue Target Engagement of CD3 Bispecific Antibodies 2025 ·Pharmaceutics ·(unknown), Stephan Schaller, Luis David Jiménez‐Franco, Alexander Kulesza, Wilhelmus E. A. de Witte, (unknown), C. Andrew Boswell, Danielle Mandikian, Chi‐Chung Li	0
2	Evaluation of Safety and Dosimetry of ¹⁷⁷Lu-DOTA-ZOL for Therapy of Bone Metastases 2021 ·Journal of Nuclear Medicine ·(unknown), Elisabeth Eppard, Wencke Lehnert, Luis David Jiménez‐Franco, Cristian Soza‐Ried, (unknown), (unknown), Andreas Kluge, Frank Rösch, Marian Meckel, Konstantin Zhernosekov, Vasko Kramer, Horacio Amaral	18
3	Automated and robust organ segmentation for 3D-based internal dose calculation 2021 ·EJNMMI Research ·(unknown), Luis David Jiménez‐Franco, Michael Schroeder, Andreas Kluge, Marcus Bronzel, (unknown)	14
4	Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), Mark Konijnenberg, Luis David Jiménez‐Franco, Andreas Kluge, Egbert Oosterwijk, Peter F.A. Mulders, Mark Rijpkema	41
5	Performance assessment of the ALBIRA II pre-clinical SPECT S102 system for 99mTc imaging 2020 ·Annals of Nuclear Medicine ·(unknown), Deni Hardiansyah, (unknown), Luis David Jiménez‐Franco, Mareike Roscher, Björn Wängler, Gerhard Glatting	2
6	FAPI-74 PET/CT Using Either¹⁸F-AlF or Cold-Kit⁶⁸Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients 2020 ·Journal of Nuclear Medicine ·Frederik L. Giesel, Sebastian Adeberg, Mustafa Syed, Thomas Lindner, Luis David Jiménez‐Franco, Eleni Mavriopoulou, Fabian Staudinger, Eric Tonndorf‐Martini, Sebastian Regnery, Stefan Rieken, Rami A. El Shafie, Manuel Röhrich, Paul Flechsig, Andreas Kluge, Annette Altmann, Jürgen Debus, Uwe Haberkorn, Clemens Kratochwil	192
7	Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in ¹⁷⁷Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment 2020 ·Journal of Nuclear Medicine ·Luis David Jiménez‐Franco, Gerhard Glatting, Vikas Prasad, Wolfgang Weber, Ambros J. Beer, Peter Kletting	21
8	MITIGATE-NeoBOMB1, a Phase I/IIa Study to Evaluate Safety, Pharmacokinetics, and Preliminary Imaging of ⁶⁸Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients 2020 ·Journal of Nuclear Medicine ·Leonhard Gruber, Luis David Jiménez‐Franco, Clemens Decristoforo, Christian Uprimny, Gerhard Glatting, Peter Hohenberger, Stefan O. Schoenberg, Wolfgang Reindl, Francesca Orlandi, (unknown), Werner Jaschke, Irene Virgolini	46
9	Biodistribution and dosimetry of a single dose of albumin-binding ligand [177Lu]Lu-PSMA-ALB-56 in patients with mCRPC 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Vasko Kramer, (unknown), Wencke Lehnert, Luis David Jiménez‐Franco, Cristian Soza‐Ried, Elisabeth Eppard, (unknown), Marian Meckel, Martina Benešová, Christoph A. Umbricht, Andreas Kluge, Roger Schibli, Konstantin Zhernosekov, Horacio Amaral, Cristina Müller	51
10	Möglichkeiten zur Verbesserung der Dosimetrie und Therapieplanung in der Molekularen Radiotherapie durch maschinelles Lernen 2019 ·Der Nuklearmediziner ·Luis David Jiménez‐Franco, Peter Kletting, Gerhard Glatting	0
11	Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands 2019 ·Nuclear Medicine and Biology ·Gordon Winter, (unknown), Luis David Jiménez‐Franco, (unknown), (unknown), Christoph Solbach, Ambros J. Beer, Gerhard Glatting, Peter Kletting	10
12	Treatment planning algorithm for peptide receptor radionuclide therapy considering multiple tumor lesions and organs at risk 2018 ·Medical Physics ·Luis David Jiménez‐Franco, Peter Kletting, Ambros J. Beer, Gerhard Glatting	23
13	Development of a tongue machine interface for quadriplegic patients 2017 ·(unknown), (unknown), (unknown), Luis David Jiménez‐Franco, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact